Product Details
| Product Name:
Devazepide |
CAS No.:
103420-77-5 |
| Purity:
99.55% |
Supply Ability:
10g |
| Release date:
2026/06/01 |
Product Introduction
Bioactivity
| Name | Devazepide |
| Description | Devazepide is a competitive, selective, orally available non-peptide CCK1 (cholecystokinin 1) receptor antagonist that inhibits bladder cancer cell proliferation and migration while inducing apoptosis and cell cycle arrest. |
| In vivo | Oral gavage administration of Devazepide (4?mg/kg, twice daily) significantly accelerated cholesterol crystal formation, crystal growth until developing into microlithiasis, and promoted gallstone formation in mice [2].
Intraperitoneal injection of Devazepide (0.1–1?mg/kg) exerted opposing regulatory effects on the basal spontaneous activity of mice and the hypokinesia induced by caerulein and apomorphine [3]. |
| Storage | Keep away from moisture,Keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 160 mg/mL (391.72 mM), Sonication is recommended.
|
| Keywords | Rat pancreatic CCK receptor | MK 329 | Guinea pig brain CCK receptor | Devazepide | Bovine gallbladder CCK receptor |
| Inhibitors Related | Stavudine | Aceglutamide | Urea | Tamoxifen | Cysteamine hydrochloride | Metronidazole | Citric Acid Triammonium | Formamide | Dimethyl phthalate | Alginic acid | Sodium Molybdate | Sildenafil citrate |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
|
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States